James Yao

Rare Disease / Clinical Research

M.D. Anderson Cancer Center

PI on 2 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Growth delay due to insulin-like growth factor I resistance
Carcinoid syndrome
Somatostatinoma
Insulinoma
Hereditary gastric cancer
Duodenal neuroendocrine tumor
Zollinger-Ellison syndrome
Glucagonoma

Clinical trials (2)

NCT01204476
NCT00454363

Verify independently

ClinicalTrials.gov PI search for James Yao

Other specialists for Growth delay due to insulin-like growth factor I resistance

Peers ranked by clinical-trial PI role, publications, and verification quality.

Armando Santoro, MD
Istituto Clinico Humanitas
Shancheng Ren, MD,PhD
Shanghai Changzheng Hospital
Robert O'Donnell
University of California, Davis
Andrew B Hassan, BMBCh FRCP
University of Oxford
Alberto Chiappori, MD
Moffitt Cancer Center
FL
Kevin Judy, MD, MD
Thomas Jefferson University
PA
Eric Burak, PhD
Centre for Probe Development and Commercialization
Michael Bergqvist, M.D., Ph.D
Uppsala University Hospital

See all specialists for Growth delay due to insulin-like growth factor I resistance →

← Back to specialists directory